logo-loader

OptiBiotix Health CEO updates on new deal with Actial Farmaceutica and launch of WellBiome

Published: 11:07 01 Jul 2020 EDT

OptiBiotix Health's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott following the news they've signed a distribution deal covering Australia, New Zealand, Indonesia, and Thailand for its cholesterol and blood pressure reducing dietary supplements, CholBiome and CholBiome X3. It's with Actial Farmaceutica - an Italian business with operations in Asia focused on probiotics and gut health. O'Hara also expands on the announcement from earlier this week around the launch of WellBiome, a blend of fibres and minerals to promote the diversity of the gut microbiome.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

1 hour, 53 minutes ago